Yunnan Botanee Bio Technology Group 2024 Q3 Quarterly Report
Quarterly Report 2024 Q3 of Yunnan Botanee Bio-Technology Group Co., Ltd. 1 Stock Code: 300957 Stock Abbreviation: Botanee Announcement No.: 2024- 053 Yunnan Botanee Bio-Technology Group Co., Ltd. 2024 Q3 Quarterly Report Botanee and all members of the Board of Directors guarantee that the information disclosed herein is true, accurate and complete without false hoods, misleading statement s or major omissions. Notices: 1. Botanee’s Board of Directors, Board of Supervisors, as well as directors, supervisors and senior management officers guarantee that the present quarterly report is true, accurate and complete without false hoods, misleading statements or major omissions, and undertake individual and joint legal liabilities arising therefrom. 2. Botanee’s legal representative Mr. Guo Zhenyu, CFO Mr. Wang Long, and Head of Accounting Department Mr. Liu Zhaofeng hereby declare that the financial information herein is authentic, accurate, and complete. 3. Whether this Q3 report has been audited or not: □ Yes No Quarterly Report 2024 Q3 of Yunnan Botanee Bio-Technology Group Co., Ltd. 2 I. Key financial data (i) Major Accounting Data and Financial Indicators Whether the Company needs to retrospectively adjust or restate the accounting data for the previous years □ Yes No This Reporting Period Change in the Reporting Period (%) From the beginning of the year to the end of the Reporting Period Change in the period from the beginning of the year to the end of the Reporting Period(%) Operating revenue(RMB) 1,213,087,219.34 14.04% 4,017,760,019.31 17.09% Net profit attributable to shareholders of the listed companies (RMB) -68,999,289.50 -153.41% 414,768,732.22 -28.39% Net profit attributable to shareholders of the listed company after deducting non-recurring Gains and Losses (RMB) -78,224,976.78 -158.23% 341,368,837.06 -32.81% Net cash flows from operating activities (RMB) 6,430,018.31 -94.83% Basic earnings per share (RMB/share) -0.16 -151.61% 0.99 -27.74% Diluted earnings per share (RMB/share) -0.16 -153.33% 0.98 -27.94% Weighted average ROE -1.16% Decrease by 3.41 percentage points 7.07% Decrease by 3.11 percentage points End of the reporting period End of the Previous Year Change in the End of This Reporting Year over the End of the Previous Year (%) Total assets (RMB) 7,804,443,170.41 7,506,930,342.79 3.96% Owners' equity attributable to shareholders of listed companies (RMB) 5,903,907,588.93 5,860,994,371.02 0.73% Whether the Company’s share capital has changed and affected the amount of shareholders’ equity due to secondary public offering,placement; allotment; ESOP exercise , buybacks and other reasons from the end of the reporting period to the disclosure date of the quarterly report. Yes □No Current reporting period Beginning of year to end of reporting period Dividends for Preferred Shares That Have Been Paid ( RMB) Interest Paid on Perpetual Bonds ( RMB) Fully Diluted Dividends per Share Based on Latest
Yunnan Botanee Bio Technology Group 2024 Q3 Quarterly Report,点击即可下载。报告格式为PDF,大小0.76M,页数22页,欢迎下载。